DE2102245A1 - Verfahren zur Herstellung von Antisera - Google Patents

Verfahren zur Herstellung von Antisera

Info

Publication number
DE2102245A1
DE2102245A1 DE19712102245 DE2102245A DE2102245A1 DE 2102245 A1 DE2102245 A1 DE 2102245A1 DE 19712102245 DE19712102245 DE 19712102245 DE 2102245 A DE2102245 A DE 2102245A DE 2102245 A1 DE2102245 A1 DE 2102245A1
Authority
DE
Germany
Prior art keywords
antisera
antigens
antigen
cells
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712102245
Other languages
German (de)
English (en)
Inventor
Dimitri London Viza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of DE2102245A1 publication Critical patent/DE2102245A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19712102245 1970-01-21 1971-01-19 Verfahren zur Herstellung von Antisera Pending DE2102245A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2854/70A GB1291134A (en) 1970-01-21 1970-01-21 A process for the production of mammal cell anti-sera

Publications (1)

Publication Number Publication Date
DE2102245A1 true DE2102245A1 (de) 1971-08-12

Family

ID=9747225

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712102245 Pending DE2102245A1 (de) 1970-01-21 1971-01-19 Verfahren zur Herstellung von Antisera

Country Status (8)

Country Link
CA (1) CA953215A (https=)
CH (1) CH530793A (https=)
DE (1) DE2102245A1 (https=)
ES (1) ES387472A1 (https=)
FR (1) FR2081446B1 (https=)
GB (1) GB1291134A (https=)
NL (1) NL7100777A (https=)
ZA (1) ZA71167B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS548714A (en) * 1977-06-16 1979-01-23 Saikin Kagaku Kenkiyuushiyo Kk Production of specific antiserum
IN149012B (https=) * 1978-04-20 1981-08-15 Duncan Lee Mccollester

Also Published As

Publication number Publication date
ZA71167B (en) 1972-11-29
CA953215A (en) 1974-08-20
ES387472A1 (es) 1974-01-01
CH530793A (fr) 1972-11-30
NL7100777A (https=) 1971-07-23
FR2081446A1 (https=) 1971-12-03
FR2081446B1 (https=) 1975-04-18
GB1291134A (en) 1972-09-27

Similar Documents

Publication Publication Date Title
DE2049515A1 (de) Impfstoff gegen Virushepatitis
DE2648458A1 (de) Reagenz zur diagnose von krebs, dessen herstellung und anwendung
EP0021152A1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
EP0279460A1 (de) Virusantigen, Verfahren zu seiner Gewinnung und Anwendung in Diagnose und Therapie (Impfstoff)
DE3019847A1 (de) Verfahren zur herstellung von menschlichem interferon und es enthaltende mittel
DE69220939T2 (de) Gegengift immunsera
DE2102245A1 (de) Verfahren zur Herstellung von Antisera
DE3413339A1 (de) Gegen pilze der gattung candida gerichtete antikoerper
DE3410694C2 (https=)
DE3424640A1 (de) Verfahren zur gewinnung und/oder bestimmung von humanspezifischem interferon im blut
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DE2742835A1 (de) Antigenfraktionen von schistosoma mansoni-eiern, geeignet fuer die untersuchung von schistosomiasis
CH639667A5 (de) Verfahren zur herstellung von peptidkomplexen aus dns-haltigen organismen.
DE2333740A1 (de) Antigen, verfahren zu dessen isolierung, bestimmung und dessen verwendung
DE2243237A1 (de) Nachweis der immunreaktion gegenueber krebs
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen
DE2353035B2 (de) Verfahren zur Stabilisierung menschlicher oder tierischer Körperflüssigkeiten oder pflanzlicher Extrakte
DE2533183C3 (de) Verfahren zum Herstellen gereinigter Immunglobuline
DE2728802C2 (de) Verfahren zum Herstellen eines antischistosomen immunologischen Mittels
DE3913438A1 (de) Verfahren zum herstellen einer immunitaetsgedaechtniszellsuspension
DE68913793T2 (de) Ein von einem Human-Human-Hybridom abgeleiteter monoklonaler Antikörper und dessen Verwendung.
DE2205897C3 (de) Verfahren zur Herstellung von Antithymozytenserum
DE2606257A1 (de) Recognine
AT226372B (de) Dessaggregiertes Gammaglobulin und Verfahren zu seiner Herstellung
DE2602892A1 (de) Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung